Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Millard

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Emerging Infectious Diseases|April 20, 2023
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TBJames Millard, Stephanie Rimmer, Camus Nimmo, et al.
BMJ (Clinical Research Ed.)|February 28, 2015
Multidrug resistant tuberculosisJames Millard, Cesar Ugarte-Gil, David A J Moore
Microorganisms|June 15, 2023
Exploitation of a Type 1 Toxin-Antitoxin System as an Inducible Counter-Selective Marker for Genome Editing in the Acetogen <i>Eubacterium limosum</i>James Millard, Alexander Agius, Ying Zhang, et al.
Open Forum Infectious Diseases|September 1, 2021
QT Interval Prolongation in People Treated With Bedaquiline for Drug-Resistant Tuberculosis Under Programmatic Conditions: A Retrospective Cohort StudySharon Isralls, Kathy Baisley, Eric Ngam, et al.
ACS Synthetic Biology|May 11, 2022
Design, Analysis, and Implementation of a Novel Biochemical Pathway for Ethylene Glycol Production in <i>Clostridium autoethanogenum</i>Barbara Bourgade, Christopher M Humphreys, James Millard, et al.
Frontiers in Cellular and Infection Microbiology|October 24, 2022
Evolution of <i>Mycobacterium tuberculosis</i> drug resistance in the genomic eraCamus Nimmo, James Millard, Valwynne Faulkner, et al.
Frontiers in Bioengineering and Biotechnology|July 10, 2023
Endogenous CRISPR/Cas systems for genome engineering in the acetogens <i>Acetobacterium woodii</i> and <i>Clostridium autoethanogenum</i>Margaux Poulalier-Delavelle, Jonathan P Baker, James Millard, et al.
Antimicrobial Agents and Chemotherapy|January 23, 2020
<i>N</i>-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and <i>N</i>-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis TreatmentThuli Mthiyane, James Millard, John Adamson, et al.
Ebiomedicine|May 4, 2020
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatmentCamus Nimmo, Kayleen Brien, James Millard, et al.
Physiotherapy Canada. Physiotherapie Canada|January 10, 2014
Beliefs and practice patterns in spinal manipulation and spinal motion palpation reported by canadian manipulative physiotherapistsLisa C Carlesso, Joy C Macdermid, P Lina Santaguida, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Emerging Infectious Diseases|April 20, 2023
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TBJames Millard, Stephanie Rimmer, Camus Nimmo, et al.
BMJ (Clinical Research Ed.)|February 28, 2015
Multidrug resistant tuberculosisJames Millard, Cesar Ugarte-Gil, David A J Moore
Microorganisms|June 15, 2023
Exploitation of a Type 1 Toxin-Antitoxin System as an Inducible Counter-Selective Marker for Genome Editing in the Acetogen <i>Eubacterium limosum</i>James Millard, Alexander Agius, Ying Zhang, et al.
Open Forum Infectious Diseases|September 1, 2021
QT Interval Prolongation in People Treated With Bedaquiline for Drug-Resistant Tuberculosis Under Programmatic Conditions: A Retrospective Cohort StudySharon Isralls, Kathy Baisley, Eric Ngam, et al.
ACS Synthetic Biology|May 11, 2022
Design, Analysis, and Implementation of a Novel Biochemical Pathway for Ethylene Glycol Production in <i>Clostridium autoethanogenum</i>Barbara Bourgade, Christopher M Humphreys, James Millard, et al.
Frontiers in Cellular and Infection Microbiology|October 24, 2022
Evolution of <i>Mycobacterium tuberculosis</i> drug resistance in the genomic eraCamus Nimmo, James Millard, Valwynne Faulkner, et al.
Frontiers in Bioengineering and Biotechnology|July 10, 2023
Endogenous CRISPR/Cas systems for genome engineering in the acetogens <i>Acetobacterium woodii</i> and <i>Clostridium autoethanogenum</i>Margaux Poulalier-Delavelle, Jonathan P Baker, James Millard, et al.
Antimicrobial Agents and Chemotherapy|January 23, 2020
<i>N</i>-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and <i>N</i>-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis TreatmentThuli Mthiyane, James Millard, John Adamson, et al.
Ebiomedicine|May 4, 2020
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatmentCamus Nimmo, Kayleen Brien, James Millard, et al.
Physiotherapy Canada. Physiotherapie Canada|January 10, 2014
Beliefs and practice patterns in spinal manipulation and spinal motion palpation reported by canadian manipulative physiotherapistsLisa C Carlesso, Joy C Macdermid, P Lina Santaguida, et al.
Pageof 2